Letters, we've got letters...

Quality of Referral Letters Written By Family Physicians to Otologists -A Peer Assessment

Introduction: Otolaryngology is a field with a high referral rate; however, there is a dearth of research on the quality of referral letters written in this field. This study was carried out to explicitly assess the quality of referral letters, more specifically in the field of otology.   Materials and Methods: Two otologists assessed referral letters written by general ...

بررسی و نقد سند و متن یک حدیث تفسیری دربارۀ حروف مقطعۀ قرآن

The Quranic Muqatta'a letters are one of the Quranic topics about which scholars expressed different viewpoints. Considering the interpretation of these letters and the intention of God, many various views have been mentioned. Some narrations are found to interpret these letters. For example, a hadith in Maani al-Akhbar of Sheikh Saduq has interpreted all these letters. This hadith is assumed t...

Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters

Background For the purpose of understanding the Food and Drug Administration’s (FDA’s) concerns regarding online promotion of prescription drugs advertised directly to consumers, this study examines notices of violations (NOVs) and warning letters issued by the FDA to pharmaceutical manufacturers.   Methods The FDA’s warning letters and NOVs, which were issued to pharmaceutical companies over a...

Looking Beyond FDA Warning Letters to Explore Unforeseen Trouble Spots in eDTCA: A Response to Recent Commentaries

Considering the Future of Pharmaceutical Promotions in Social Media; Comment on “Trouble Spots in Online Direct-to-Consumer Prescription Drug Promotion: A Content Analysis of FDA Warning Letters”

This commentary explores the implications of increased social media marketing by drug manufacturers, based on findings in Hyosun Kim’s article of the major themes in recent Food and Drug Administration (FDA) warning letters and notices of violation regarding online direct-to-consumer promotions of pharmaceuticals. Kim’s rigorous analysis of FDA letters over a 10-year span highlights a relative ...